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Background: Among individuals diagnosed with the chronic neurologic disease, multiple sclerosis (MS), a majority
suffers from fatigue, which strongly influences their every-day-life. The aim of this study was to investigate work
capacity and health-related quality of life (HRQoL) in a group of MS patients and also to investigate if work capacity
and HRQoL could be predicted by background factors, fatigue, heat sensitivity, cognitive dysfunction, emotional
distress or degree of disability.
Methods: A descriptive, cross-sectional, designed survey was undertaken A questionnaire was sent to 323
individuals diagnosed with MS, aged between 20 and 65 years, with physical disability on the expanded disability
status score (EDSS) in the interval 0 ≥ EDSS ≤ 6.5, living in Östergötland county in eastern Sweden. Questions on
background factors, occupation and work, together with the health-related quality of life short form instrument
(SF-36), the fatigue severity scale (FSS), the perceived deficit questionnaire (PDQ) and the hospital anxiety
depression scale (HAD) were posed. Associations between variables were analyzed using Pearson’s and Spearman’s
correlations. Differences between groups were tested using the Chi-square test, the Mann Whitney U-test, and the
Student’s t-test. Predictive factors were analyzed using multiple linear and multiple logistic regression analysis.
Results: Of those who completed the questionnaire (n = 257, 79.6%), 59.8% were working. Work capacity was
found significantly more among men (p < 0.005), those with a higher level of education (p < 0.001), those reporting
less fatigue (p < 0.001), and those having no heat sensitivity (p = 0.004). For work capacity, significant predictors
were low physical disability (EDSS), low fatigue, higher level of education, male sex and lower age. Those with work
capacity showed significantly higher HRQoL than those who had no work capacity (p < 0.001). Levels of fatigue,
cognition and emotional distress were found to be major contributing factors for HRQoL.
Conclusions: Work capacity and HRQoL among individuals diagnosed with MS are highly influenced by fatigue
which can be considered as a key symptom. Work capacity was influenced by heat-sensitivity, cognitive difficulties
and emotional distress and significant predictive factors besides fatigue, were physical disability (EDSS), age, sex,
and level of education. Remaining at work also gives a better HRQoL.
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Among people visiting general practitioners, fatigue is
the major reason for the visit in five to seven percent
[1], and among people in the working population,
21 - 23% have been found to suffer from fatigue [2,3].
There is no single explanation for what causes fatigue,
but it often accompanies chronic diseases [4-6].
Among individuals with the chronic neurologic dis-
ease, multiple sclerosis (MS), the majority, 60-80%, re-
port that they suffer from fatigue [3,7]. As many as one
third of MS-patients noted fatigue as their very first
symptom and they noted it before other neurological
signs of the disease became apparent [8]. The experience
of MS-related fatigue is described as quite distinguished
from any prior experiences of feeling tired [9]. Fatigue
related to MS is strongly influencing the individuals’
daily lives [3,5,10], and reduces their quality of life
[11,12].
Onset of MS often happens in early adulthood, 70% in
20–40 years of age [13] and life expectancy is long,
about 65 years of age [14], which means that many
people in the Western world are affected. For example,
in European countries there are about half a million
people diagnosed with MS [15]. In Sweden, prevalence
studies show that about 180/100 000 inhabitants have
been diagnosed with MS [16,17]. To a large extent, MS
is a female problem and women get MS about twice as
often as men; in Sweden, recently reported sex ratios are
2.65 and 2.35 (female/male) [16,18]. In about 70-80% of
cases, the initial course is relapsing-remitting (RR) [13],
however, after an average of 15 years and in about 70%
of cases, the RR course changes to a secondary progres-
sive course (SP) characterized by increasing disability. In
20%, the course is progressive from the onset, called pri-
mary progressive course (PP) [13]. Among young and
middle aged adults, MS is the main reason for disability
and limitations in functional abilities [19]. The young
age of onset in MS makes it one of the major causes of
reduced work capacity due to neurologic disease in
Western society. Importantly, of all its symptoms, a ma-
jority of the individuals with MS consider fatigue as the
most handicapping and as their worst problem [3]. Indi-
viduals with a RR-course of the disease have, in a large
sample and a longitudinal study, been found to have less
severe fatigue compared to individuals with a SP or
PP-course [20].
Besides fatigue, individuals with MS may experience
other problems influencing their work capacity and
quality of life. Cognitive difficulties such as memory and
attention problems [9,21] are found as affecting about
half of the individuals with MS and described as a lead-
ing cause of perceived disability in MS [22,23]. Among a
group of young MS-patients [24], one third showed
cognitive impairment in complex attention, i.e. in rapidshifting between competing stimuli, which was assumed
to affect their work and career [24].
However, there have also been reported differences
between self- graded cognitive function and observed
neuropsychological performance [25].
Another well-known feature of fatigue in MS is its
association with depression and over 50% experience
emotional distress, a symptom intertwined with the ex-
periences of fatigue and health related quality of life
[26,27]. Subsequently, several frequent MS symptoms
appear concurrently: fatigue, depression, cognitive dys-
function and, in addition to these, heat sensitivity which
has been increasingly focused upon [28-31]. Heat sensi-
tivity has been shown to increase fatigue and other
common MS-symptoms, like pain and difficulties con-
centrating [31-33], all of which may influence individ-
uals’ disability and work capacity.
Reduced capacity to work is a major cause of the high
cost of MS in society, as are the costs associated with
the need for personal care in later stages of the disease.
One study showed that the cost of MS in Sweden is
about €600 million a year, one third of which are indir-
ect costs associated with loss of production [34]. In a
Danish study [35], people with MS left paid work earlier
than people in the general population. After five years,
30% of MS patients (n = 2 538) had retired early, com-
pared to 3% in the control group and twenty years later
the proportions were 78% compared to 14% respectively.
In a Swedish study from the early 1990s, about 50% of
those with MS were on full sick leave [36], compared to
37.5% in a recent study [37]. The earlier studies [35,36]
were performed before immune-modulating drugs were
introduced and currently many patients with MS are
treated with such drugs, the effects of which have been
focused on in relation to both fatigue and work ability.
These drugs may decrease the development of disability
[38] and increase work ability [37], but they may also in-
crease fatigue [39,40].
This study is part of a wider project on the topic of
MS fatigue carried out in Östergötland county in eastern
Sweden by our research group [3,31,41]. In this study,
work capacity and health related quality of life (HRQoL)
among individuals diagnosed with MS aged 65 or youn-
ger were investigated and, further, whether work status
and HRQoL can be predicted by background factors, fa-
tigue, heat sensitivity, cognitive dysfunction, emotional
distress or degree of disability were analyzed.
Methods
Study group
A descriptive, cross-sectional, designed survey was un-
dertaken. Recruitment to the study was done among
people living in Östergötland county in eastern Sweden
who were registered in the Swedish MS register (SMS
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established: i) diagnosed with MS, ii) of working age, i.e.
between 20 and 65 years, 65 years is the official retire-
ment age in Sweden, and iii) having an Expanded Dis-
ability Status Score (EDSS) [42] in the interval 0 ≥
EDSS ≤ 6.5. Using EDSS, an individual’s physical disabil-
ity is measured based on ratings of neurological signs of
neurological functions and ambulation, graded in twenty
steps ranging from zero to ten. An EDSS = 0 indicates
normal neurological conditions, while EDSS = 10 indicates
the individual’s death due to MS. In this study, the chosen
interval of EDSS indicates that most of the individuals are
mobile and can walk at least short distances [42].
A package containing an information letter about the
study, a questionnaire and a pre-paid reply envelope was
sent to each of the 323 individuals fulfilling the criteria,
239 women and 84 men. The questionnaires were dis-
tributed in 2007 and 2008. One reminder was sent to
those who had not answered within three weeks. Other
analyses and results have been published from this
study [31].
Data collection
Information about the participants’ age and sex, disease
course, actual disability assessed with EDSS [42] and
date of onset was acquired from the SMS register. Both
the patient’s disease-course and EDSS are continuously
upgraded when visiting a physician at the neurological
policlinic. The participants were grouped according to
normal neurological condition (EDSS = 0), mild disability
(1.0 ≥ EDSS ≤ 3.5), moderate disability (4.0 ≥ EDSS ≤ 5.5)
and severe disability (6.0 ≥ EDSS ≤ 6.5).
Information on background factors such as the partici-
pants’ civil status, family, level of education together
with on-going medical treatment was requested in the
questionnaire. In one question, the participants’ occupa-
tion and to what degree they worked, were requested.
The participants specified if they were working full-time,
part-time or not working. In the case of part-time work,
the participants reported percentages of full-time. They
also reported if they were on full- or part-time sick leave
or received a disability pension. Ongoing education and
training and working at home were considered as
equivalent to work. In one question, the participants
were asked “Are you sensitive to heat?” (Yes/No).
HRQoL was assessed using the Swedish version of the
well-tested and extensively used generic instrument
short form SF-36 Health Survey [43-45]. The question-
naire measures eight health domains (subscales): phys-
ical functioning (PF), role-physical (RP), bodily pain
(BP), general health (GH), vitality (VT), social function-
ing (SF), role-emotional (RE), and mental health (MH).
Each subscale contains 2 to 10 items, for a total of 35 ques-
tions. In an additional item, the respondents rated theircurrent health status compared to one year previously on a
five-point scale (1 =much better to 5 =much worse).
Subscale scores are computed according to standardized
procedures and range from 0 to 100, in which higher
scores indicate better health related quality of life [43,46].
To investigate the perceived severity of fatigue, the
Fatigue Severity Scale (FSS) [47] was used, comprising
nine items with each item graded from least fatigue (1)
to severe fatigue (7). As in earlier studies [e.g. 7, 48], an
FSS mean score ≤4 was regarded as indicating no fa-
tigue, >4 but <5 indicated borderline fatigue, and ≥5 in-
dicated severe fatigue. The FSS is widely used both
clinically and in research [48]. In this study, concurrent
validity was assessed through correlations between the
FSS total with questions about the impact of fatigue on
daily life and the impact on the ability to work, and
resulted in r =0.79 (p < 0.01) and r =0.75 (p < 0.01) re-
spectively. Reliability was assessed using Cronbach’s
alpha [49], and the alpha coefficient was 0.93 [31].
To investigate perceived problems with memory, at-
tention and concentration, the Perceived Deficit Ques-
tionnaire (PDQ) [50] was translated from the original
English into Swedish. The Swedish version was back-
translated in accordance with Streiner and Norman [51].
In PDQ, 20 items are graded from never (0) to always
(4), and summated scores vary from 0 to 80, higher
scores indicate greater cognitive problems. Concurrent
validity was estimated by calculating correlations be-
tween the PDQ sum score and the graded occurrence of
two MS symptoms, forgetfulness and difficulties concen-
trating (never = 0 to always = 5) and resulted in r = 0.75
(p < 0.010) and r = 0.73 (p < 0.010) respectively. These re-
sults indicate that there is evidence of concurrent valid-
ity for PDQ in this study group. Reliability was tested
using Cronbach’s alpha, the alpha coefficient was 0.95,
and the split-half technique (r = 0.87).
To investigate the occurrence of emotional distress,
the widely used Hospital Anxiety Depression (HAD)
scale was applied [52]. In seven items, occurrence of
symptoms mirroring anxiety and depressive symptoms
respectively are graded from zero to three. Summated
scores range from 0 to 21 and identify non-cases (score
7 or less), doubtful cases (scores in the interval 8–10)
and definitive cases (scores 11 or higher). In this study,
reliability assessed using Cronbach’s alpha, resulted in
the alpha coefficient for anxiety being 0.88 and for de-
pression 0.87.
Statistical analyses
The descriptive statistics used are numbers and per
cents, median and interquartile-range (IQR) mean and
standard deviation (SD). The scales FSS, PDQ and SF-36
are treated on interval levels as in earlier studies. Associ-
ations between variables were tested by Pearson’s or
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groups were tested with the Chi-square test on data on a
nominal level, with the Mann Whitney U-test on data
on an ordinal level, and Student’s t-test on data on an
interval level. In the multiple logistic regression analyses
(enter), the capacity for work, dichotomised as capacity
(full or limited = 1) or no capacity (full-time sick leave or
disability pension = 0) was entered as a dependent vari-
able, and fatigue (FSS-mean), heat sensitivity, cognition,
emotional distress, disability, age, gender (female = 1/
male = 2), and level of education (compulsory = 1, sec-
ondary school or university = 2) as independent vari-
ables. The correlation between age and having children
was rs = 0.78, therefore, age was used in the logistic ana-
lyses model. In the multiple linear regression analyses
(enter) the domains in HRQoL measured by SF-36 were
used as dependent variables, and fatigue, heat sensitivity,
cognition, anxiety, depression, disability, age and gender
were used as independent variables.
Ethical considerations
Common ethical principals in research, and in accord-
ance with the Declaration of Helsinki [53], were applied
in the study. Approval to use the SMS register was re-
ceived from the local administrator responsible for the
register. The Regional Ethical Review Board at the Fac-
ulty of Health Sciences, Linköping University, Sweden
(Dnr M13-07) also approved the study. A completed
and returned questionnaire was considered received in-
formed consent.
Results
Participants
Two hundred and fifty seven participants (79.6%) res-
ponded to the invitation and returned a completed ques-
tionnaire; of the surveyed, 76.3% were women and
23.7% were men. There were no significant differences
between non-respondents and respondents regarding sex
(p = 0.066), disease-course (p = 0.064) or EDSS score
(p = 0.142). The participants’ mean age was 47.5 years
(SD10.8), the women (n = 196) were older (48.2 years, SD
11.0) than the men (n = 61), (44.8 years, SD10.1) (p = 0.033)
(Table 1), while the non-respondents were five years
younger on average, m = 42.7 years (SD 10.5) (p < 0.001).
Work capacity
Of the respondents, 59.8% reported that they worked
full- or part-time. Regarding background factors in rela-
tion to work capacity, significantly more women than
men were on full-time sick leave or disability pension
(Table 1). Those participants who had capacity to
work were younger, mean age 44.5 years (SD10.4)
compared to those who had non-capacity to work, mean
age 51.8 years (SD10.2) (p < 0.001). Besides disability,significant differences between the levels of capacity to
work were found, for example, regarding fatigue, heat
sensitivity, cognitive difficulties and emotional distress
(Table 2).
Fatigue (FSS-mean) correlated significantly with cogni-
tive difficulties (PDQ-sum), r = 0.51 (p < 0.001). The par-
ticipants who reported that they were sensitive to heat
(n = 146) also reported significantly more cognitive diffi-
culties compared to those who were not sensitive to
heat (n = 108), mean 29.5 (SD14.8) and 22.6 (SD14.4),
(p < 0.001), respectively.
Seventy five percent of the participants with a univer-
sity education (n = 88) reported that they were working,
compared to 51.5% of the participants with compulsory
or secondary school education (n = 167) (p < 0.001). The
latter graded significantly more cognitive difficulties than
the participants with a university education, mean 29.3
(SD15.3) and 21.6 (SD12.9), (p < 0.001), respectively.
In a multiple logistic regression analysis, (enter), 54%
of the capacity for work was explained by the model.
Significant factors in the model were fatigue (FSS-mean)
(OR = 0.75, p = 0.041), disability assessed by EDSS (OR =
0.53, p <0.001), sex (OR = 4.34, p = 0.001), level of
education (OR = 3.88, p = 0.002) and age (OR = 0.93,
p <0.001) (Table 3).
Health-related quality of life
Fatigue significantly influenced daily life (p < 0.001).
Among those participants who reported that they were
sensitive to heat, self-rated health (first item in the SF-
36) was rated significantly worse (mean 3.5, SD 0.83)
compared to those who were not sensitive to heat (mean
3.2, SD 0.92) (p = 0.015). HRQoL was graded signifi-
cantly higher in all SF-36 domains among those who
were working full- or part-time compared to those who
did not work (Table 4).
In the multiple linear regression analyses, fatigue was
significantly related to HRQoL in all SF-36 domains ex-
cept role-emotional and mental health (Table 5).
Discussion
This study is a cross-sectional study and a questionnaire
was used to collect the data. The response rate, nearly
80%, is consistent with what is common in similar stud-
ies. In this study, the women were somewhat older than
the men and were also more often retired due to the dis-
ease, while more men reported they had work capacity.
Regarding civil status, level of education, course of dis-
ease and disability or pharmacological treatment, there
were no significant differences between women and
men, except for work capacity.
Fatigue proved to be a significant factor influencing
work capacity. Those participants who had the capacity
to work reported significantly less fatigue compared to
Table 1 Sample characteristics
Women (n = 196) Men (n = 61) P-value
Age, years Mean (SD) 48.2 (11) 44.8 (10) 0.033
Civil status, n (%)
Married/cohabitant, n 141(72) 44 (72) 0.959
Living alone, n 55 (28) 17 (28)
Education, n (%)
Lower: Compulsory – Secondary school 123 (63) 45 (70) 0.125
Higher: After secondary school – University 72 (37) 16 (30)
Missing data 1
Occupation
Working, full- or part-time, n (%) 106 (54) 47 (77) 0.005
Not working, n (%) 89 (46) 14 (23)
Missing data 1
Course of the disease, n (%)
Relapsing – remitting (RR) 140 (71) 47 (77) 0.389
Progressive (PP + SP) 56 (29) 14 (23)
Disease severity, n (%)
No neurological signs, EDSS = 0 20 (10) 7 (11) 0.560
Mild, 1.0≤ EDSS≤ 3.5 119 (61) 38 (62)
Moderate, 4.0≤ EDSS≤ 5.5 21 (11) 9 (15)
Severe, 6.0≤ EDSS≤ 6.5 36 (18) 7 (11)
Medication
No pharmacological treatment, n (%) 45 (23) 9 (15) 0.164
Pharmacological treatment, n (%) 150 (77) 52 (85)
Immune-modulating treatment
Yes, n (%) 103 (53) 41 (67) 0.828
No, n (%) 93 (47) 20 (33)
Characteristics of participants (n = 257).
Flensner et al. BMC Public Health 2013, 13:224 Page 5 of 10
http://www.biomedcentral.com/1471-2458/13/224those with no capacity to work. Another fact was that
the level of work capacity was statistically significantly
higher among those participants who were not sensitive
to heat, while those who were sensitive to heat showed
significantly more often a non-capacity to work. In a
previous study, heat sensitivity was found to significantly
interfere with and also increase fatigue [31]. In this
study, fatigue could be seen as a key symptom influen-
cing both work capacity and HRQoL.
Similar to the findings in this study, Krokavcova et al.
[54] found that patients with self-rated good health are
more likely to be employed. In this study, participants
who had the capacity to work graded both better health
and HRQoL than those with a non-capacity to work.
Interestingly, a higher level of education was shown as
a significant predictive factor for work capacity in this
study. The reason for this may be discussed in terms of
disability level and work of a person, which demands
that the person is movable, or that educational attain-
ment has not been disrupted due to MS. This might bedependent of the age at onset of the disease [24]. In the
present study, just a few percent of the participants
(5.5%) had onset of the disease before 20 years of age
[31]. Blue collar work usually consists of physical labor
which naturally is influenced by actual disability, while
work requiring higher education might more often be
paperwork or white collar work. This result indicates the
importance of supporting young MS-patients in continu-
ing their education, even at a higher level. This would
also be in line with the results presented by Glad and
colleagues [26], who found that having a RR-course,
higher education and light physical work were predicting
factors for being able to remain employed.
Another interesting aspect of the increased work cap-
acity of patients with higher education is that cognitive
problems in MS are a common feature. However, obvi-
ously, in this study, such problems did not interfere with
work, probably based on intellectual processes, which
required higher education. However, MS is a complex
disease and regarding fatigue, multiple factors might
Table 2 Participants in relation to capacity to work or non capacity to work
Capacity to work (n = 153) Non capacity to work (n = 103) P-value
Fatigue, FSS, range 1-7
- Mean (SD) 4.2 (1.6) 5.3 (1.4) < 0.001
Heat- sensitivity, n
- Yes, n = 148 (%) 77 (52) 71 (48)
- No, n = 108 (%) 76 (70) 32 (30) 0.004
Cognitive dysfunction, PDQ, range, 0-80
- Mean (SD) 24.2 (13.5) 30.0 (16.2) 0.002
Education
- Compulsory and secondary school, n (%) 86 (57) 81 (79)
- University, n (%) 66 (43) 22 (21) < 0.001
Emotional distress, HAD,
- Anxiety (HAD), range 0–21, Md (IQR) 3 (6) 6 (7) 0.303
- Depressed (HAD), range 0–21, Md (IQR) 3 (4) 4 (6) 0.002
Disability
- Normal neurological status (EDSS = 0), n (%) 25 (92) 2 (8)
- Mild disability (EDSS 1.0 – 3.5), n (%) 113 (72) 44 (28) < 0.001
- Moderate disability (EDSS 4.0 – 5.5), n (%) 9 (31) 20 (69)
- Severe disability (EDSS 6.0-6.5), n (%) 6 (14) 37 (86)
Medication
- No pharmacological treatment, n (%) 23 (15) 30 (29) 0.007
- Pharmacological treatment, n (%) 129 (85) 73 (71)
Immune-modulating treatment
- Yes, n (%) 109 (71) 36 (35) < 0.001
- No, n (%) 44 (29) 63 (65)
Capacity to work (full- or part-time) or non capacity to work described in relation to fatigue (FSS), heat-sensitivity, cognitive dysfunction (PDQ), educational level,
anxiety and emotional distress (HAD), and disability (EDSS).
FSS = Fatigue Severity Scale;
PDQ = Perceived Disability Questionnaire;
HAD = Hospital Anxiety Depression Scale;
EDSS = Expanded Disability Status Scale;
Missing value, n = 1.
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tion. In this study in the linear regression analysis, fa-
tigue and cognition were found as contributing factors
in the domain of bodily pain and vitality. Pain may inter-
fere with and disrupt an individual’s attention and con-
centration, but also influence fatigue. An important
question is if cognitive problems in MS sometimesTable 3 Logistic regression analyses of capacity for work
Dependent variable Predictors
Capacity for work Fatigue (FSS-mean)
Disability (EDSS) (0–6.5)
Sex (male = 2)
Educational level
Age
The significant factors in the logistic regression analyses of capacity for work, dicho
fatigue, heat sensitivity, cognition, anxiety, depression, disability, gender, education
R2 Nagelkerke = 0.54.fluctuate and are secondary to fatigue. This should be of
interest to study further. However, fluctuations of cogni-
tive difficulties in MS have been found in relation to a
heat environment [31-33]. In one study, cognitive diffi-
culties were reported as eased when the individual used
a cooling-suit [29], which also should be of interest for
further investigations.OR 95%Cl P-value
0.75 0.57-0.99 0.041
0.53 0.43-0.65 <0.001
4.34 1.76-10.67 0.001
3.9 1.6-9.1 0.002
0.93 0.90-0.97 <0.001
tomized as full or limited = 1 or non capacity = 0 as a dependent variable, and
al level and age as independent variables.
Table 4 Health-related quality of life
Capacity to work Non capacity to work P-value
Health-related Quality of life (SF-36)
- Physical functioning, mean (SD) 75.5 (22.0) 41.7 (26.4) < 0.001
- Role functioning, mean (SD) 55.0 (39.5) 25.8 (36.3) < 0.001
- Body pain, mean (SD) 71.1 (27.2) 53.4 (29.7) < 0.001
- General health, mean (SD) 56.8 (22.3) 42.7 (18.9) < 0.001
- Vitality, mean (SD) 50.9 (22.5) 38.6 (23.5) < 0.001
- Social functioning, mean (SD) 71.2 (25.5) 59.3 (26.3) < 0.001
- Role emotional, mean (SD) 72.0 (37.9) 57.0 (45.7) 0.005
- Mental health, mean (SD) 73.1 (20.3) 64.7 (20.6) 0.002
Health-related quality of life (HRQoL) (SF-36) in relation to capacity to work (full or part-time) or non capacity to work.
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correlation analysis we found that age and having chil-
dren were closely correlated (rs = 0.78) why we chose to
keep age as the independent variable. In our original hy-
pothesis, however, we paid an interest in MS patientsTable 5 Multiple regression analyses of the domains in health
Dependent domains SF-36 Significant independent
variables
Physical functioning (PF) Fatigue (FSS)
Disability (EDSS)
Age
Role physical (RP) Fatigue (FSS)
Depression (HAD-D)
Gender
Bodily pain (BP) Fatigue (FSS)
Cognition(PDQ)
Anxiety – HAD-A
Depression – HAD-D
Age
General health (GH) Fatigue (FSS)
Anxiety (HAD-A)
Age
Vitality (VT) Fatigue(FSS)
Cognition (PDQ)
Depression(HAD-D)
Social functioning (SF) Fatigue (FSS)
Depression (HAD-D)
Role emotional (RE) Heat sensitivity
Anxiety (HAD-A)
Depression (HAD-D)
Mental health (MH) Anxiety(HAD-A)
Depression (HAD-D)
Multiple linear regression analyses of the domains in health-related quality of life m
sensitivity, cognition, anxiety, depression, disability, age and gender as independenwith small children since this situation may increase
their level of fatigue. As age appeared as a predictor we
also suggest that it stands for having small children.
Quality of life was assessed as significantly higher
among those who worked, a result also found in earlier-related quality of life
Standardized ß P-value Adjusted R2 in
the model
-.240 <0.001 0.57
-.594 <0.001
-.120 0.008
-.451 <0.001 0.39
-.201 0.009
.118 0.026
-.197 0.004 0.31
-.159 0.042
-.145 0.052
-.154 0.055
-.134 0.019
-.322 <0.001 0.35
-.164 0.028
-.136 0.016
-.562 <0.001 0.60
-.123 0.038
-.182 0.003
-.387 <0.001 0.42
-.299 <0.001
-.107 0.054 0.39
-.234 <0.001
-.322 <0.001
-.447 <0.001 0.60
-.376 <0.001
easured by SF-36 and used as a dependent variable and fatigue, heat
t variables.
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nificant factor influencing all domains of health-related
quality of life, except role-emotional and mental health,
while cognition was a significant factor influencing two
of the domains, bodily pain and vitality. In the domain
of role-emotional, heat sensitivity appeared as a signifi-
cant influencing factor which might be understood as
limiting the individuals’ social life activities.
The impact of fatigue on quality of life is obviously
connected to work ability, a central function in every-
body’s life. For natural reasons, the risk of isolation in
society increases both through unemployment and the
obstacles it places to participating in family life on equal
terms. In conclusion, the impact on these domains could
very well affect the individual’s sense of coherence which
is central to the individual’s perception of wellbeing. As
fatigue is a symptom with a severe impact on quality of
life and work capacity, it is important to find the organic
cause which, in the case of MS, justifies a patient’s sick
leave and disability pension.
Another point of view is that being able to work is of
importance for the quality of life of people with chronic
diseases. People with MS, should have the opportunity
to work part-time as long as possible. As people with
MS are often affected early on in life, their occupational
development is more difficult. The fact that young
people may be stopped by MS from working at all
should also be taken into account.
Apart from disability measured by EDSS, the fact that
heat sensitivity interferes with work capacity suggests
that organising cryotherapeutic approaches in the work
place, such as air conditioning, cooling garments and
disability friendly measures should be put in place.
This article also focuses on fatigue as a common and
serious symptom in MS already at the onset and the fol-
lowing stages of the disease. For example, general practi-
tioners should take MS-fatigue into consideration when
young patients complain about tiredness. Subsequently,
it is necessary that patients are properly diagnosed early
on in the course of a disease like MS, indicating that
physicians should be careful when diagnosing a common
symptom like tiredness or mental/physical exhaustion in
young people, especially females. However, all patients
who complain of fatigue cannot be referred to a neurolo-
gist. The Swedish sick leave system relies on patients
being diagnosed. Clear recommendations are made in
order to determine the appropriate sick leave period
with a specific diagnosis. This means that a patient with-
out a specific diagnosis, i.e. a rather symptomatic de-
scription, like tiredness, pain, etc., may find it difficult to
receive financial compensation from the Swedish sick
leave insurance system. One study from our group has
revealed that although a very high percentage of MS pa-
tients showed no sign of neurological dysfunction whenphysically examined, in fact, almost 25%, suffered from
pathological tiredness – fatigue – as the only subjective
symptom [41].
Limitations
A limitation of the study is associated with the chosen
design, no causal explanations and no follow up. The
sample included 323 individuals why self-assessment
questionnaires were used. Thus, data rely on self-
assessments and on the subjective experiences of the
participants. The use of a generic instrument to investi-
gate HRQoL (SF36) can be criticized since it does not
cover specific MS-symptoms. However, the SF36 is a
well known instrument and widely used in other studies,
why the results may be easier to interpret and can also
be compared with other groups in the future.
Conclusions
Work capacity and HRQoL among individuals diagnosed
with MS are highly influenced by fatigue which, thus, can
be considered as a key symptom. Work capacity was also
influenced by heat-sensitivity, cognitive difficulties and
emotional distress and significant predictive factors be-
sides fatigue were physical disability, age, sex, and educa-
tional level. Remaining at work also gave a better HRQoL.
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